Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Differentiation of neuroblastoma cells by phorbol esters and insulin-like growth factor 1 is associated with induction of retinoic acid receptor β gene expression

Oncogene volume 18, pages 5393–5402 (1999)Cite this article

Abstract

The retinoic acid (RA) receptor β isoform (RARβ) plays an important role in RA-induced differentiation of human neuroblastoma. In this study we show that insulin-like growth factor 1 (IGF-1) and tetradecanoyl phorbol acetate (TPA) induce RARβ gene expression in neuroblastoma SH-SY5Y cells. IGF-1 and TPA caused a marked induction of RARβ2 promoter activity and had a synergistic effect with RA that also upregulates transcription. The effect of RA is mediated by two RA responsive elements (RAREs), whereas the IGF-1 and TPA actions are independent of the RAREs and map to sequences that overlap the TATA box. These results suggest that the signaling pathways stimulated by TPA and IGF-1 could modify the components assembled at the core RARβ2 promoter and activate transcription. Expression of RasVal12 mimics the effect of IGF-1 and TPA on the promoter, and a dominant negative Ras mutant abrogates activation. A dominant negative Raf also blocks activation showing that the Ras-Raf pathway mediates stimulation of the RARβ2 promoter. Our results show that neuronal differentiation induced by non-retinoid agents that activate Ras is accompanied by increased transcription of the RARβ gene.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bjelfman C, Meyerson G, Cartwright CA, Mellstrom K, Hammerling U and Pahlman S. . 1990 Mol. Cell. Biol. 10: 361–370.

  • Calés C, Hancock JF, Marshall CJ and Hall A. . 1988 Nature 332: 548–551.

  • Carpentier A, Balitrand N, Rochette-Egly C, Shroot B, Degos L and Chomienne C. . 1997 Oncogene 9: 1805–1813.

  • Cheung B, Hocker JE, Smith SA, Reichert U, Norris MD, Haber M, Steward BW and Marshall GM. . 1996 Biochem. Biophys. Res. Commun. 229: 349–354.

  • De Thé H, Vivanco Ruiz MdM, Tiollais P, Stunnenberg HG and Dejean A. . 1990 Nature 343: 177–180.

  • Desmarais D and Royal A. . 1996 J. Biol. Chem. 271: 24976–24981.

  • Dey A, Minucci and Ozato K. . 1994 Mol. Cell. Biol. 14: 8191–8201.

  • Feig L and Cooper GM. . 1998 Mol. Cell. Biol. 8: 3235–3243.

  • Giannini G, Dawson MI, Zhang X-k and Thiele CJ. . 1997 J. Biol. Chem. 272: 26693–26701.

  • Glass CK. . 1994 Endocr. Rev. 15: 391–407.

  • Gudas LJ, Sporn MB and Roberts AB (ed). . 1994 The Retinoids: Cellular Biology and Biochemistry of the Retinoids. Raven Press: New York pp. 443–520.

    Google Scholar 

  • Hampsey M and Reinberg D. . 1997 Curr. Biol. 7: R44–46.

  • Haussler M, Sidell N, Kelly M, Donaldson C, Altman A and Mangelsdorf D. . 1983 Proc. Natl. Acad. Sci. USA 80: 5525–5529.

  • Iriving H, Lovat PE, Hewson QC, Malcolm AJ, Pearson AD and Redfern CP. . 1998 Eur. J. Cancer 34: 111–117.

  • Kaplan DR, Matsumoto K, Lucarelli E and Thiele CJ. . 1993 Neuron 11: 321–331.

  • Kastner P, Mark M and Chambon P. . 1995 Cell 83: 859–869.

  • Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkerzeller G, Marme D, Rapp UR. . 1993 Nature 364: 249–252.

  • Kruyt FAE, Folkers G, Van den Brink CE and van der Saag PT. . 1992 Nucl. Acid. Res. 20: 6393–6399.

  • Leitman DC, Mackopw ER, Williams T, Baxter JD and West BL. . 1992 Mol. Cell. Biol. 12: 1352–1356.

  • LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT. . 1995 Endocr. Rev. 16: 143–163.

  • Lieberman PM and Berk AJ. . 1994 Genes Dev. 8: 995–1006.

  • Lovat PE, Pearson ADJ, Malcolm A and Redfern CPF. . 1993 Neurosci. Lett. 162: 109–113.

  • Lovat PE, Irving H, Annichiarico-Petruzzelli M, Bernassola F, Malcolm AJ, Pearson AD, Melino G and Redfern CP. . 1997 Eur. J. Cancer. 33: 2075–2080.

  • Mangelsdorf DJ and Evans RM. . 1995 Cell 83: 841–850.

  • Nakagawara A, Azar CG, Scavarda NJ and Brodeur GM. . 1994 Mol. Cell. Biol. 14: 759–767.

  • Nishizuka Y. . 1995 FASEB J. 9: 484–496.

  • Pahlman S, Meyerson G, Lindgren E, Schalling M and Johansson I. . 1991 Proc. Natl. Acad. Sci. USA 88: 9994–9998.

  • Parrow V, Nanberg E, Heikkila J, Hammerling U and Pahlman S. . 1992 J. Cell. Physiol. 152: 536–544.

  • Pawson T. . 1992 Curr. Opin. Genet. 2: 4–12.

  • Redfern CPF, Lovat PE, Malcolm AJ and Pearson ADJ. . 1994 Biochem. J. 304: 147–154.

  • Rochette-Egly C, Adam S, Rossignol M, Egly J-M and Chambon P. . 1997 Cell 90: 97–197.

  • Rodríguez-Viciana P, Warne PH, Dhand R, Vanhaesegroek B, Gout I, Fry MJ, Waterfield MD and Downward J. . 1994 Nature 370: 527–532.

  • Ruberte E, Dolle P, Chambon P, Morriss-Kay G. . 1991 Development 111: 45–60.

  • Schonthal A. . 1992 New Biol. 4: 16–21.

  • Sanguedolce M, Leblanc BP, Betz JL and Stunnenberg HG. . 1997 EMBO J. 16: 2861–2867.

  • Su B and Karin M. . 1996 Curr. Opin. Immunol. 8: 402–411.

  • Sucov HM, Murakami KK and Evans RM. . 1990 Proc. Natl. Acad. Sci. USA 87: 5392–5396.

  • Sumantran VN and Feldman EL. . 1993 Endocrinology 132: 2017–2023.

  • Taneja R, Rochette-Egly C, Plassat J-L, Penna L, Gaub M-P and Chambon P. . 1997 EMBO J. 16: 6452–6465.

  • Thiele CJ. . 1991 Cancer Metast. Rev. 10: 311–319.

  • Thiele C, Reynolds C and Israel M. . 1985 Nature 313: 404–406.

  • Torchia J, Glass CK and Rosenfeld MG. . 1998 Curr. Opin. Cell. Biol. 10: 373–383.

  • Villablanca JG, Khan AA, Avramis VI, Seeger RC, Mathay KK, Ramsay NKC, Reynolds CP. . 1995 J. Clin. Oncol. 13: 894–901.

  • Vivanco-Ruiz MdM, Bugge TH, Hirschmann P and Stunnerberg HG. . 1991 EMBO J. 10: 3829–3838.

  • Wefald FC, Devlin BH and Williams RS. . 1990 Nature 344: 260–262.

  • Weigel LN. . 1996 Biochem. J. 319: 657–667.

  • Zechel C, Shen X-Q, Chen J-Y, Chambon P and Gronemeyer H. . 1994 EMBO J. 13: 1425–1433.

  • Zelent A, Krust A, Petkovich M, Kustner P and Chambon P. . 1989 Nature 339: 714–717.

Download references

Acknowledgements

We thank H Stunnenberg for constructs containing the RARβ 2 promoter, E Santos for the Ras and Raf vectors, and P Chambon for the receptor antibodies used in this study. We also thank Jorge Martinez de la Mata for his valuable aid. This work has been supported by Grant PM97-0135 from the DGES and 08.1/0032 from the Comunidad de Madrid. G Pérez-Juste is a Fellow from the Comunidad de Madrid.

Author information

Authors and Affiliations

  1. Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Arturo Duperier 4, Madrid, 28029, Spain

    German Perez-Juste & Ana Aranda

Authors
  1. German Perez-Juste
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Aranda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perez-Juste, G., Aranda, A. Differentiation of neuroblastoma cells by phorbol esters and insulin-like growth factor 1 is associated with induction of retinoic acid receptor β gene expression. Oncogene 18, 5393–5402 (1999). https://doi.org/10.1038/sj.onc.1202906

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202906

Keywords

This article is cited by

Search

Advanced search

Quick links